Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Woo, Hyun Goo ^a   Kim, Soon Sun ^a   Cho, Hyunwoo ^a   Kwon, So Mee ^a   Cho, Hyo Jung ^a   Ahn, Seun Joo ^a   Park, Eun Sung ^b   Lee, Ju Seog ^c   Cho, Sung Won ^a   Cheong, Jae Youn ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; CHROMOSOME 1Q; CLINICAL ARTICLE; CONTROLLED STUDY; CTNNB1 GENE; EARLY CANCER; EXOME; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; HEPATITIS B; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; SOMATIC MUTATION; TRANSCRIPTOMICS; CARCINOMA, HEPATOCELLULAR; CLONAL EVOLUTION; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; MUTATION;

HEPATITIS B VIRUS;

BETA CATENIN; CTNNB1 PROTEIN, HUMAN;

BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CLONAL EVOLUTION; EXOME; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MUTATION;

EID: 84919483713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115152     Document Type: Article

References (40)

1. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, et al. (2011) Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 140: 1063-1070.
2. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, et al. (2001) Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120: 1763-1773.
3. Nakagawa H, Shibata T (2013) Comprehensive genome sequencing of the liver cancer genome. Cancer Lett 340: 234-240.
4. Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, et al. (2011) High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 43: 464-469.
5. Huang J, Deng Q, Wang Q, Li KY, Dai JH, et al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 44: 1117-1121.
6. Sung WK, Zheng H, Li S, Chen R, Liu X, et al. (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet.
7. Cleary SP, Jeck WR, Zhao X, Chen K, Selitsky SR, et al. (2013) Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology 58: 1693-1702.
8. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, et al. (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44: 760-764.
9. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, et al. (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44: 694-698.
10. Kan Z, Zheng H, Liu X, Li S, Barber TD, et al. (2013) Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 23: 1422-1433.
11. Li M, Zhao H, Zhang X, Wood LD, Anders RA, et al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43: 828-829.
12. Tao Y, Ruan J, Yeh SH, Lu X, Wang Y, et al. (2011) Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A 108: 12042-12047.
13. Ikeda A, Shimizu T, Matsumoto Y, Fujii Y, Eso Y, et al. (2014) Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma. Gastroenterology 146: 222-232 e235.
14. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, et al. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.
15. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
16. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
17. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
18. Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164.
19. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
20. Woo HG, Lee JH, Yoon JH, Kim CY, Lee HS, et al. (2010) Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res 70: 3034-3041.
21. Clark MJ, Chen R, Lam HY, Karczewski KJ, Chen R, et al. (2011) Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 29: 908-914.
22. Wang Q, Jia P, Li F, Chen H, Ji H, et al. (2013) Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med 5: 91.
23. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883-892.
24. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell 149: 979-993.
25. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, et al. (2013) Signatures of mutational processes in human cancer. Nature 500: 415-421.
26. Supek F, Minana B, Valcarcel J, Gabaldon T, Lehner B (2014) Synonymous mutations frequently act as driver mutations in human cancers. Cell 156: 1324-1335.
27. Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, et al. (2013) Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A 110: 13481-13486.
28. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, et al. (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet Chapter 10: Unit 10 11.
29. Huang H (1999) Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155: 1795-1801.
30. Thorvaldsdottir H, Robinson JT, Mesirov JP (2013) Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14: 178-192.
31. Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, et al. (2013) Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 45: 478-486.
32. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14: 1188-1190.
33. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, et al. (2010) GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26: 2927-2928.
34. Calvisi DF, Factor VM, Loi R, Thorgeirsson SS (2001) Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res 61: 2085-2091.
35. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, et al. (2000) Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770.
36. Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, et al. (2002) Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 8: 450-456.
37. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499: 214-218.
38. Kwon SM, Cho H, Choi JH, Jee BA, Jo Y, et al. (2012) Perspectives of integrative cancer genomics in next generation sequencing era. Genomics Inform 10: 69-73.
39. Woo HG, Park ES, Lee JS, Lee YH, Ishikawa T, et al. (2009) Identification of potential driver genes in human liver carcinoma by genomewide screening. Cancer Res 69: 4059-4066.
40. Poon TC, Wong N, Lai PB, Rattray M, Johnson PJ, et al. (2006) A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. Gastroenterology 131: 1262-1270.